These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2289475)

  • 1. Time-dependent pro- and anticonvulsant effects of cysteamine on the development and expression of amygdaloid kindled seizures.
    Takazawa A; Abraham WC; Bilkey DK
    Epilepsy Res; 1990 Nov; 7(2):86-94. PubMed ID: 2289475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of kindled seizures by cysteamine: dependence on injection-to-kindled seizure interval.
    Cottrell GA; Robertson HA
    Eur J Pharmacol; 1987 Feb; 134(2):225-8. PubMed ID: 3569411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amygdaloid kindling and kindled seizures in rats receiving chronic ethanol administration.
    Mello LE; Masur J; Formigoni ML; Kireeff W; Cavalheiro EA
    Epilepsy Res; 1990 Nov; 7(2):95-104. PubMed ID: 2289476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoclonus inducing and seizure modifying effect of cysteamine on cortical and amygdaloid kindled rats.
    Takazawa A; Bilkey DK
    Brain Res; 1988 Nov; 473(1):99-106. PubMed ID: 3145096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profound suppression of kindled seizures by cysteamine: possible role of somatostatin to kindled seizures.
    Higuchi T; Sikand GS; Kato N; Wada JA; Friesen HG
    Brain Res; 1983 Dec; 288(1-2):359-62. PubMed ID: 6140981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dextromethorphan, a nonopioid antitussive, on development and expression of amygdaloid kindled seizures.
    Takazawa A; Anderson P; Abraham WC
    Epilepsia; 1990; 31(5):496-502. PubMed ID: 2401241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AWD 140-190: a potent anticonvulsant in the amygdala-kindling model of partial epilepsy.
    Tober C; Löscher W; Hönack D; Bartsch R
    Epilepsia; 2001 May; 42(5):590-9. PubMed ID: 11380565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteamine suppresses kindled seizures in pentylenetetrazol-kindled rats.
    Assouline G; Barkaie E; Gutnick MJ
    Eur J Pharmacol; 1984 Nov; 106(3):649-52. PubMed ID: 6151512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CL 218,872 a triazolopyridazine with a selective affinity for the benzodiazepine BZ1 receptor subtype, retards the development and expression of amygdaloid-kindled seizures: effects of flumazenil.
    McNamara RK; Corcoran ME
    Epilepsy Res; 1993 Sep; 16(1):19-26. PubMed ID: 7902274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective effect of 2-chloroadenosine against the development of amygdala kindling and on amygdala-kindled seizures.
    Abdul-Ghani AS; Attwell PJ; Bradford HF
    Eur J Pharmacol; 1997 May; 326(1):7-14. PubMed ID: 9178649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine treatment during amygdala-kindled seizure development fails to inhibit seizures and diminishes subsequent anticonvulsant efficacy.
    Postma T; Krupp E; Li XL; Post RM; Weiss SR
    Epilepsia; 2000 Dec; 41(12):1514-21. PubMed ID: 11114208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of amygdaloid kindling by diazepam in juvenile rats.
    Albertson TE; Stark LG; Derlet RW
    Brain Res Dev Brain Res; 1990 Feb; 51(2):249-52. PubMed ID: 2323033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat.
    Young NA; Lewis SJ; Vajda FJ; Beart PM
    Exp Neurol; 1989 Feb; 103(2):199-202. PubMed ID: 2536332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cysteamine on somatostatin-like immunoreactivity in the amygdala-kindled rat brain.
    Pitkänen A; Hyttinen JM; Riekkinen PJ
    Neuropeptides; 1989 Jul; 14(1):11-6. PubMed ID: 2571106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of cysteamine-induced myoclonus blocks the long-term inhibition of kindled seizures.
    Cottrell GA; Robertson HA
    Brain Res; 1987 May; 412(1):161-4. PubMed ID: 3607450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of technical, biological, and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. V. Lack of seasonal influences on amygdala kindling in rats.
    Wlaź P; Löscher W
    Epilepsy Res; 1993 Oct; 16(2):131-6. PubMed ID: 8269911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anticonvulsant effects of progesterone and 5alpha-dihydroprogesterone on amygdala-kindled seizures in rats.
    Lonsdale D; Burnham WM
    Epilepsia; 2003 Dec; 44(12):1494-9. PubMed ID: 14636318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant action of fluzinamide (AHR-8559) on kindled amygdaloid seizures.
    Albertson TE; Joy RM; Stark LG
    Epilepsia; 1984 Aug; 25(4):511-7. PubMed ID: 6745221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anticonvulsant action of AHR-11748 on kindled amygdaloid seizures in rats.
    Albertson TE; Walby WF
    Epilepsy Res; 1987 Mar; 1(2):126-33. PubMed ID: 3504388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a glycine derivative (CP 1552-S) on kindled seizures in rats.
    Albertson TE; Stark LG; Joy RM
    Neuropharmacology; 1984 Aug; 23(8):967-70. PubMed ID: 6483120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.